- Home
- AVXL vs ELLO Comparison
AVXL vs ELLO Comparison
Compare AVXL & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVXL | ELLO |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 237.2M | 255.4M |
| IPO Year | 2013 | 1998 |
Fundamental Metrics
Financial Performance| Metric | AVXL | ELLO |
|---|---|---|
| Price | $2.44 | $20.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 677.9K | 2.4K |
| Earning Date | 05-08-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.26 | $17.00 |
| 52 Week High | $10.38 | $30.34 |
Technical Indicators
Market Signals| Indicator | AVXL | ELLO |
|---|---|---|
| Relative Strength Index (RSI) | 38.03 | 49.75 |
| Support Level | $2.33 | $18.03 |
| Resistance Level | $2.80 | $20.40 |
| Average True Range (ATR) | 0.16 | 0.89 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 4.42 | 41.27 |
Price Performance
Historical ComparisonAbout AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.